Drug Depot, Inc., dba APS Pharmacy 2022-04-06 Health serious FDA
Health · FDA · Recall #FDA-D-0732-2022
TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable, Packaged in a multi dose 10ML… Recall
Issued April 6, 2022 · Drug Depot, Inc., dba APS Pharmacy
In April 2022, Drug Depot, Inc., dba APS Pharmacy recalled the TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable, Packaged in a multi dose 10ML…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of sterility assurance.
What you should do
- 1 Stop using TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable, Packaged in a multi dose 10ML… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Drug Depot, Inc., dba APS Pharmacy to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Drug Depot, Inc., dba APS Pharmacy
- Category
- Health
- Recall date
- April 6, 2022
- Units affected
- Not reported
- Sold at
- Nationwide in the USA including Puerto Rico.
- Recall number
- FDA-D-0732-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Drug Depot, Inc., dba APS Pharmacy has 4 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.